tiprankstipranks
Trending News
More News >
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
US Market

Cartesian Therapeutics (RNAC) Cash flow

Compare
1,138 Followers

Cartesian Therapeutics Cash Flow

RNAC's free cash flow for Q3 2025 was $-16.89M. For the 2025 fiscal year, RNAC's free cash flow was decreased by $18.60M and operating cash flow was $-15.60M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -23.67M$ -51.16M$ -31.63M$ -60.38M$ 34.88M
Investing Cash Flow
$ -8.74M$ 34.61M$ -15.00M$ -17.14M$ -741.00K
Financing Cash Flow
$ 168.43M$ -13.14M$ 39.22M$ 52.90M$ 14.43M
End Cash Position
$ 214.28M$ 78.29M$ 108.04M$ 115.44M$ 140.06M
Free Cash Flow
$ -32.77M$ -51.37M$ -32.83M$ -61.47M$ 34.07M
Currency in USD

Cartesian Therapeutics Cash Flow